Joost L. Boormans
Erasmus MC, Erasmus MC Cancer Institute, Erasmus University Rotterdam
Papers
7
Total Citations
112
H-Index
4
About
Dr. Joost L. Boormans is a leading urologic oncologist whose research centers on optimizing surgical management for bladder cancer and upper tract urothelial carcinoma (UTUC). His major contributions lie in comparative effectiveness research, systematically evaluating robot-assisted versus open surgical approaches. Through a landmark multicentre study, he demonstrated that robot-assisted radical cystectomy (RARC) offers comparable oncological outcomes to open surgery, while providing critical insights into perioperative recovery and healthcare costs. His work on radical nephroureterectomy for UTUC, involving a large multinational cohort with propensity-score matching, has helped clarify the relative benefits of open, laparoscopic, and robotic techniques. Boormans has also advanced the field by examining the prognostic significance of positive surgical margins after cystectomy, aiding in the identification of patients who may benefit from adjuvant therapy. More recently, he has pioneered research into the environmental impact of bladder cancer care, quantifying the carbon footprint and staff demands of surgery versus chemoradiation. With over 100 citations across his most influential papers, Boormans’ work directly informs clinical guidelines and surgical decision-making, establishing him as a key voice in evidence-based urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7